vcp205
Vaccineexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00000904)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vcp205
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00076817 | Phase 1 | Jun 1, 2006 | National Institute of Allergy and Infectious Diseases (NIAID), University of California, Los Angeles |
| NCT00013572 | Phase 1 | Mar 21, 2001 | United States Army |
| NCT00001136 | Phase 1 | Jan 25, 2000 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00000879 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT00000904 | Phase 1 | Nov 2, 1999 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 4 | 4 | 1 | 1999 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 1999 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 1999 |
| United States Army | Government | 1 | 1 | 1 | 2001 |
| University of California, Los Angeles | Academic/Hospital | 1 | 0 | 1 | 2006 |
5 organizations
Page 1 / 1